Malignant biphasic uterine tumours: Carcinosarcomas or metaplastic carcinomas?

Journal of Clinical Pathology

Volumn 55, Issue 5, 2002, Pages 321-325

  McCluggage, W Glenn ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOSARCOMA; CELL TYPE; CELL ULTRASTRUCTURE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM CARCINOMA; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; METAPLASIA; NOMENCLATURE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STEM CELL; UTERUS CARCINOMA;

EID: 0036261049     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.55.5.321     Document Type: Review

References (57)

1. Tumors of the uterine corpus and gestational trophoblastic disease
2. Carcinosarcoma of the ovary treated over a 10 year period at the Christie hospital
3. Malignant mullerian mixed tumors of the uterine cervix: A report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus
4. Primary malignant mixed Mullerian tumor (metaplastic carcinoma) of the female peritoneum - A clinical, pathological and immunohistochemical study of three cases and a review of the literature
5. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus
6. Evidence for a common etiology for endometrial carcinomas and malignant mixed Mullerian tumors
7. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus
8. Uterine carcinosarcomas in patients receiving tamoxifen: A report of 19 cases
9. Uterine carcinosarcoma in association with tamoxifen therapy
10. Long term tamoxifen treatment: A possible aetiological factor in the development of uterine carcinosarcoma: Two case reports and review of the literature
11. Tamoxifen and malignant epithelial-nonepithelial tumors of the endometrium: Report of six cases and review of the literature
12. Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer
13. Is there an association between long term tamoxifen treatment and the development of carcinosarcoma (malignant mixed Mullerian tumor) of the uterus?
14. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: Further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis
15. Mesenchymal tumors of the uterus II. A clinical and pathologic study of 31 mixed mesodermal tumors
16. Mesenchymal tumors of the uterus III. A clinical and pathologic study of 31 carcinosarcomas
17. Carcinosarcoma of the uterus: A 40 year experience from the state of Missouri
18. Prognostic factors in early stage uterine sarcoma: A gynecologic oncology study group
19. Malignant mixed Mullerian tumor verses high grade endometrial carcinoma and aggressive variants of endometrial carcinoma: A comparative analysis of survival
20. Prognostic features of sarcomas and mixed tumors of the endometrium
21. Malignant mixed mullerian tumors of the uterus
22. Uterine sarcoma: Analysis of prognostic variables in 71 cases
23. Mullerian mixed tumour of the uterine corpus: A clinical histopathological review of 28 patients
24. Prognostic factors in malignant mesodermal (mullerian) mixed tumors of the uterus
25. Malignant mixed mullerian tumors of the uterus
26. Malignant mixed Mullerian tumors: An immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation
27. Prognostic factors in uterine carcinosarcoma. A clinicopathologic study of 25 patients
28. An evaluation of prognostic factors in uterine carcinosarcoma
29. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus
30. Carcinosarcoma (malignant mixed mullerian (mesodermal) tumor) of the uterus and ovary: Correlation of clinical, pathologic and immunohistochemical features in 29 cases
31. Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: Immunohistochemical and ultrastructural analysis of 28 cases
32. Malignant mixed mullerian tumors: An ultrastructural and immunohistochemical analysis with histogenic consideration
33. The immunohistochemical profile of malignant mixed mullerian tumor: Overlap with endometrial adenocarcinoma
34. p53 immunostaining suggests that uterine carcinosarcomas are monoclonal
35. Coexpression of p53 by epithelial and stromal elements in carcinosarcoma of the female genital tract: An immunohistochemical study of 19 cases
36. The hormonal receptor status of uterine carcinosarcomas (mixed Mullerian tumours): An immunohistochemical study
37. Angiogenesis in carcinosarcoma of the uterus: Differences in the microvessel density and expression of vascular endothelial growth factor between the epithelial and mesenchymal elements
38. Markers of apoptosis and angiogenesis indicate that carcinomatous components play an important role in the malignant behaviour of uterine carcinosarcoma
39. Proliferation indices and p53 immunocytochemistry in uterine mixed mullerian tumors
40. Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma
41. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumours
42. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis
43. Carcinosarcoma (malignant mixed mullerian tumors) of the female genital tract: Comparative molecular analysis of epithelial and mesenchymal components
44. Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed Mullerian tumours
45. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity
46. Two cell lines established from mixed mullerian tumors of the uterus. Morphologic, immunocytochemical and cytogenetic analyses
47. Establishment and characterisation of carcinosarcoma cell lines of the human uterus
48. Characteristics of cloned cells of mixed mullerian tumor of the human uterus
49. Establishment and characterisation of cell lines derived from uterine malignant mixed Mullerian tumor
50. Uterine carcinosarcoma is derived from a single stem cell: An in situ study
51. Heterotransplantation of mixed mesodermal tumor cells in nude mouse - Histology of metastatic foci
52. The histogenesis of carcinosarcoma (mixed mesodermal tumor) of the uterus as revealed by tissue culture studies
53. Collision of endometrioid carcinoma and stromal sarcoma of the uterus: A report of two cases
54. Collision of uterine rhabdoid tumor and endometrioid adenocarcinoma: A case report and review of the literature
55. The effect of chemotherapy on the different components of advanced carcinosarcomas (malignant mixed mesodermal tumors) of the female genital tract
56. Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcoma of the uterus: A gynecologic oncology group study
57. A randomised study of adriamycin with and without DTIC in advanced uterine sarcomas